Erythrocytapheresis

PROCEDURE2 trials

Sponsors

Sanquin Research & Blood Bank Divisions, Murdoch Childrens Research Institute

Conditions

HemochromatosisHereditary Haemochromatosis

Phase 3

Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy

CompletedNCT00202436

Sanquin Research & Blood Bank DivisionsHemochromatosis

Start: 2004-10-31End: 2009-09-30Target: 40Updated: 2009-10-20

Unknown Phase

Mi-iron - Moderately Increased Iron - is Reducing Iron Overload Necessary?

CompletedNCT01631708

Murdoch Childrens Research InstituteHereditary Haemochromatosis

Start: 2012-06-30End: 2016-07-31Updated: 2016-09-27

Related Papers

A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis

Journal of Clinical Apheresis2020-12-244 citations

Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.

2017-12-0137 citations

Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron)

BMJ Open2015-08-0119 citations